Nov. 11, 2024 — GE HealthCare and DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. have formed a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. The companies aim to develop SmartTechnology solutions that harness the power of AI to address key challenges across the imaging value chain, including helping increase the efficiency of imaging interpretation and reporting, enabling collaboration across care teams, improving the clinical interpretation of images, and enhancing operational efficiency and productivity. These new SmartTechnology solutions will seek to combine GE HealthCare’s imaging expertise and scale, RadNet’s deep experience in care delivery, and DeepHealth’s AI-powered health informatics portfolio to elevate patient care.
With the global cancer burden continuing to rise,health systems face increasing challenges and seek solutions to enhance early detection and diagnosis when treatment can be most effective. To help address these challenges, the two companies will first work to bring together DeepHealth’s AI-based SmartMammo 1 workflow and clinical solution and GE HealthCare’s patient-centric Senographe Pristina mammography system to bring AI-powered clinical imaging support to breast cancer screening.
GE HealthCare’s Senographe Pristina mammography system was designed to ease anxiety the moment the patient enters the exam room. It features an inviting gantry with elegant lighting and rounded shapes, as well as a soft-curved surface that welcomes patients into a space of comfort and support – with 83% of patients rating their experience with Senographe Pristina better and more comfortable than previous exams.3
RadNet’s DeepHealth SmartMammo is an AI-powered SaaS solution designed to seamlessly integrate into existing breast cancer diagnostic workflows, enhancing diagnostic accuracy 4 and workflow efficiency. By embedding imaging informatics into advanced mammography systems, the solution can support high-volume breast cancer screening programs. The SmartMammo offering will work to prioritize cases based on suspicion level and ensure seamless integration and interoperability with existing healthcare IT infrastructure.
SmartMammo includes:
- a cloud-native smart enterprise image viewer with PACS functionality that enables fast image loading and real-time data rendering of multimodality images, accessible from any workstation and location,
- integration with the radiologist worklist and reporting tools to streamline the workflow, and
- a suite of clinical AI detection tools that offers automatic lesion localization and degree of suspicion that are effective in diverse populations and dense breast tissue. 1,4 The cloud-native architecture of the DeepHealth OS powering SmartMammo simplifies support and maintenance while allowing for seamless feature updates and functionality enhancements without any downtime.
The two companies also seek to include Smart Alerts, a DeepHealth workflow solution to be integrated with Senographe Pristina that will use rapid AI processing with the goal of alerting imaging sites to cases with potentially suspicious lesions in minutes. This kind of solution aims to empower same-day diagnostic exams, follow-up compliance, and reduced anxiety for women with potentially suspicious findings.
The two companies’ agreement will enable GE Healthcare to distribute SmartMammo and other DeepHealth solutions to imaging providers in the United States as part of GE HealthCare’s comprehensive portfolio of imaging technologies.
In addition to collaborating on SmartMammo, GE HealthCare and RadNet’s DeepHealth intend to explore areas of further collaboration for SmartTechnology solutions in other modalities and clinical domains, to expand the access to and impact of AI-based workflows.
For more information, visit the GE HealthCare (#7330) and DeepHealth (#1340) booths at the Radiological Society of North America 2024 Annual Meeting.
To learn moreabout the companies, please visitt www.gehealthcare.com, www.radnet.com and deephealth.com
- Components of SmartMammo are 510(k) pending for use with GE HealthCare.
- https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services
- Data on file, GE Healthcare. 83% of patient assessed the exam as more comfortable than previous. IPSOS Patient Satisfaction Study sponsored by GE Healthcare, conducted with 315 patients across 2 sites in Europe.
- Kim et al. Impact of a Categorical AI System for Digital Breast Tomosynthesis on Breast Cancer Interpretation by Both General Radiologists and Breast Imaging Specialists. Radiol Artif Intell. 2024. doi: 10.1148/ryai.230137.
August 29, 2024 
